These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27676277)

  • 1. Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.
    Lima A; Bernardes M; Azevedo R; Seabra V; Medeiros R
    Pharmacogenomics; 2016 Oct; 17(15):1649-1674. PubMed ID: 27676277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine.
    Abdallah HY; Ibrahim ME; Abd El-Fadeal NM; Ali DA; Elsehrawy GG; Badr RE; Hassoba HM
    Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population.
    Lv S; Fan H; Li J; Yang H; Huang J; Shu X; Zhang L; Xu Y; Li X; Zuo J; Xiao C
    Front Pharmacol; 2018; 9():1390. PubMed ID: 30546311
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.
    Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R
    Biomed Res Int; 2014; 2014():368681. PubMed ID: 24967362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
    Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
    Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
    Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
    Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
    Owen SA; Hider SL; Martin P; Bruce IN; Barton A; Thomson W
    Pharmacogenomics J; 2013 Jun; 13(3):227-34. PubMed ID: 22450926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
    Saleh MM; Irshaid YM; Mustafa KN
    Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate impact on radiographic progression in biologic-treated rheumatoid arthritis under clinical remission: A case report on monozygotic Caucasian twins.
    Soukup T; Nekvindova J; Dosedel M; Brtkova J; Toms J; Bastecka D; Bradna P; Vlcek J; Pavek P
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):790-795. PubMed ID: 27770044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Qiu Q; Huang J; Shu X; Fan H; Zhou Y; Xiao C
    Sci Rep; 2017 Mar; 7():44015. PubMed ID: 28266606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
    Lima A; Bernardes M; Azevedo R; Medeiros R; Seabra V
    Int J Mol Sci; 2015 Jun; 16(6):13760-80. PubMed ID: 26086825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients.
    Singh A; Gangadharan H; Gupta V; Patro PS; Misra R; Aggarwal A
    Int J Rheum Dis; 2021 May; 24(5):654-662. PubMed ID: 33780152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate.
    Soukup T; Dosedel M; Nekvindova J; Antonin Kubena A; Tacheci I; Duintjer Tebbens J; Vlcek J; Bradna P; Barvik I; Pavek P
    Pharmacogenet Genomics; 2017 Feb; 27(2):43-50. PubMed ID: 27846189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
    Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
    Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.
    Kato T; Hamada A; Mori S; Saito H
    Drug Metab Pharmacokinet; 2012; 27(2):192-9. PubMed ID: 22104130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.
    Hughes LB; Beasley TM; Patel H; Tiwari HK; Morgan SL; Baggott JE; Saag KG; McNicholl J; Moreland LW; Alarcón GS; Bridges SL
    Ann Rheum Dis; 2006 Sep; 65(9):1213-8. PubMed ID: 16439441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.
    Wang SM; Sun LL; Zeng WX; Wu WS; Zhang GL
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):283-9. PubMed ID: 24908438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.